- Home
- NTLA vs LPG Comparison
NTLA vs LPG Comparison
Compare NTLA & LPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTLA
- LPG
- Stock Information
- Founded
- NTLA 2014
- LPG 2013
- Country
- NTLA United States
- LPG United States
- Employees
- NTLA N/A
- LPG N/A
- Industry
- NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- LPG Marine Transportation
- Sector
- NTLA Health Care
- LPG Consumer Discretionary
- Exchange
- NTLA Nasdaq
- LPG Nasdaq
- Market Cap
- NTLA 1.2B
- LPG 1.4B
- IPO Year
- NTLA 2016
- LPG 2014
- Fundamental
- Price
- NTLA $12.06
- LPG $31.08
- Analyst Decision
- NTLA Buy
- LPG Strong Buy
- Analyst Count
- NTLA 20
- LPG 1
- Target Price
- NTLA $32.30
- LPG $35.00
- AVG Volume (30 Days)
- NTLA 4.2M
- LPG 526.8K
- Earning Date
- NTLA 08-07-2025
- LPG 10-30-2025
- Dividend Yield
- NTLA N/A
- LPG 10.29%
- EPS Growth
- NTLA N/A
- LPG N/A
- EPS
- NTLA N/A
- LPG 1.15
- Revenue
- NTLA $52,857,000.00
- LPG $320,692,009.00
- Revenue This Year
- NTLA $8.32
- LPG $24.57
- Revenue Next Year
- NTLA N/A
- LPG N/A
- P/E Ratio
- NTLA N/A
- LPG $26.99
- Revenue Growth
- NTLA 14.99
- LPG N/A
- 52 Week Low
- NTLA $5.90
- LPG $16.66
- 52 Week High
- NTLA $23.76
- LPG $37.16
- Technical
- Relative Strength Index (RSI)
- NTLA 60.10
- LPG 55.44
- Support Level
- NTLA $11.29
- LPG $30.04
- Resistance Level
- NTLA $12.46
- LPG $32.28
- Average True Range (ATR)
- NTLA 0.56
- LPG 0.74
- MACD
- NTLA 0.12
- LPG -0.20
- Stochastic Oscillator
- NTLA 84.85
- LPG 47.14
About NTLA Intellia Therapeutics Inc.
Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.
About LPG Dorian LPG Ltd.
Dorian LPG Ltd is an international liquefied petroleum gas shipping company focused on owning and operating gas carriers, or VLGCs. The company currently owns and operates around 22 modern VLGCs, including nineteen new fuel-efficient 84,000 cbm ECO-design VLGCs. Dorian LPG has offices in Connecticut, USA, London, United Kingdom, and Athens, Greece. IT operates in one reportable segment, the international transportation of LPG.